XTAI:1733 Apex Biotechnology Corp Quarterly Report Filing - 6/30/2012

Effective Date 6/30/2012

XTAI:1733 Fair Value Estimate
Premium
XTAI:1733 Consider Buying
Premium
XTAI:1733 Consider Selling
Premium
XTAI:1733 Fair Value Uncertainty
Premium
XTAI:1733 Economic Moat
Premium
XTAI:1733 Stewardship
Premium
 
1733 2012-08-24 1733 2011-06-30 tw-gaap-ci:MinorityInterestMember 1733 2011-06-30 tw-gaap-ci:StockholdersEquitiesAdjustmentsOtherMember 1733 2011-06-30 tw-gaap-ci:EquitiesRelatedNoncurrentAssetsClassifiedHeldSaleMember 1733 2011-06-30 tw-gaap-ci:UnrealizedRevaluationIncrementMember 1733 2011-06-30 tw-gaap-ci:TreasuryStockValueMember 1733 2011-06-30 tw-gaap-ci:NetLossNotRecognizedPensionCostMember 1733 2011-06-30 tw-gaap-ci:CumulativeTranslationAdjustmentsMember 1733 2011-06-30 tw-gaap-ci:CapitalStockOtherMember 1733 2011-06-30 tw-gaap-ci:StockDividendDistributedValueMember 1733 2011-06-30 tw-gaap-ci:AdvanceReceiptsCommonStockValueMember 1733 2011-06-30 tw-gaap-ci:CertificatesBondStockConversionValueMember 1733 2011-06-30 tw-gaap-ci:PreferredStockValueMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:MinorityInterestMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:StockholdersEquitiesAdjustmentsOtherMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:EquitiesRelatedNoncurrentAssetsClassifiedHeldSaleMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:UnrealizedRevaluationIncrementMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:TreasuryStockValueMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:NetLossNotRecognizedPensionCostMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:CumulativeTranslationAdjustmentsMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:CapitalSurplusMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:CapitalStockMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:CapitalStockOtherMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:StockDividendDistributedValueMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:AdvanceReceiptsCommonStockValueMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:CertificatesBondStockConversionValueMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:PreferredStockValueMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:CommonStockValueMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:StockholdersEquitiesAdjustmentsMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:UnrealizedGainLossesFinancialInstrumentMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:LegalReserveMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:TotalStockholdersEquitiesMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:TotalParentCompanyStockholdersEquitiesMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:RetainedEarningsMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:UnappropriatedRetainedEarningsMember 1733 2011-01-01 2011-06-30 tw-gaap-ci:SpecialReserveMember 1733 2011-06-30 tw-gaap-ci:TotalStockholdersEquitiesMember 1733 2011-06-30 tw-gaap-ci:TotalParentCompanyStockholdersEquitiesMember 1733 2011-06-30 tw-gaap-ci:StockholdersEquitiesAdjustmentsMember 1733 2011-06-30 tw-gaap-ci:UnrealizedGainLossesFinancialInstrumentMember 1733 2011-06-30 tw-gaap-ci:RetainedEarningsMember 1733 2011-06-30 tw-gaap-ci:UnappropriatedRetainedEarningsMember 1733 2011-06-30 tw-gaap-ci:SpecialReserveMember 1733 2011-06-30 tw-gaap-ci:LegalReserveMember 1733 2011-06-30 tw-gaap-ci:CapitalSurplusMember 1733 2011-06-30 tw-gaap-ci:CapitalStockMember 1733 2011-06-30 tw-gaap-ci:CommonStockValueMember 1733 2012-06-30 tw-gaap-ci:MinorityInterestMember 1733 2012-06-30 tw-gaap-ci:StockholdersEquitiesAdjustmentsOtherMember 1733 2012-06-30 tw-gaap-ci:EquitiesRelatedNoncurrentAssetsClassifiedHeldSaleMember 1733 2012-06-30 tw-gaap-ci:UnrealizedRevaluationIncrementMember 1733 2012-06-30 tw-gaap-ci:TreasuryStockValueMember 1733 2012-06-30 tw-gaap-ci:NetLossNotRecognizedPensionCostMember 1733 2012-06-30 tw-gaap-ci:CumulativeTranslationAdjustmentsMember 1733 2012-06-30 tw-gaap-ci:CapitalStockOtherMember 1733 2012-06-30 tw-gaap-ci:StockDividendDistributedValueMember 1733 2012-06-30 tw-gaap-ci:AdvanceReceiptsCommonStockValueMember 1733 2012-06-30 tw-gaap-ci:CertificatesBondStockConversionValueMember 1733 2012-06-30 tw-gaap-ci:PreferredStockValueMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:MinorityInterestMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:StockholdersEquitiesAdjustmentsOtherMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:EquitiesRelatedNoncurrentAssetsClassifiedHeldSaleMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:UnrealizedRevaluationIncrementMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:TreasuryStockValueMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:NetLossNotRecognizedPensionCostMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:CumulativeTranslationAdjustmentsMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:CapitalSurplusMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:CapitalStockMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:CapitalStockOtherMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:StockDividendDistributedValueMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:AdvanceReceiptsCommonStockValueMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:CertificatesBondStockConversionValueMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:PreferredStockValueMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:CommonStockValueMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:StockholdersEquitiesAdjustmentsMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:UnrealizedGainLossesFinancialInstrumentMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:LegalReserveMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:TotalStockholdersEquitiesMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:TotalParentCompanyStockholdersEquitiesMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:RetainedEarningsMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:UnappropriatedRetainedEarningsMember 1733 2012-01-01 2012-06-30 tw-gaap-ci:SpecialReserveMember 1733 2012-06-30 tw-gaap-ci:TotalStockholdersEquitiesMember 1733 2012-06-30 tw-gaap-ci:TotalParentCompanyStockholdersEquitiesMember 1733 2012-06-30 tw-gaap-ci:StockholdersEquitiesAdjustmentsMember 1733 2012-06-30 tw-gaap-ci:UnrealizedGainLossesFinancialInstrumentMember 1733 2012-06-30 tw-gaap-ci:RetainedEarningsMember 1733 2012-06-30 tw-gaap-ci:UnappropriatedRetainedEarningsMember 1733 2012-06-30 tw-gaap-ci:SpecialReserveMember 1733 2012-06-30 tw-gaap-ci:LegalReserveMember 1733 2012-06-30 tw-gaap-ci:CapitalSurplusMember 1733 2012-06-30 tw-gaap-ci:CapitalStockMember 1733 2012-06-30 tw-gaap-ci:CommonStockValueMember 1733 2011-01-01 1733 2012-01-01 1733 2011-01-01 2011-06-30 1733 2011-06-30 1733 2012-01-01 2012-06-30 1733 2012-06-30 iso4217:TWD xbrli:shares iso4217:TWD xbrli:shares xbrli:pure 153323000 688505000 79101000 114119000 627192000 397474000 517589000 410374000 0 4569000 34912000 14514000 34912000 19083000 1412117000 1629555000 10261000 10261000 10261000 10261000 375327000 370213000 283318000 284487000 6920000 3394000 2227000 2227000 7092000 14053000 20828000 22807000 73825000 77866000 769537000 775047000 769537000 775047000 239007000 242084000 35279000 28878000 565809000 561841000 1209000 866000 1852000 2446000 3340000 0 13039000 15841000 13039000 15841000 19440000 19153000 1492000 1613000 0 41000 6000000 6000000 6000000 6000000 7492000 7654000 2015119000 2228464000 268000 0 80880000 89953000 137173000 126073000 4591000 5172000 59644000 24380000 82911000 67316000 0 401232000 48587000 42497000 2731000 1962000 51318000 445691000 214000 0 14356000 17911000 14570000 17911000 431355000 776496000 19548000 17615000 19548000 17615000 450903000 794111000 955314000 955314000 955314000 955314000 1142000 1142000 1142000 1142000 313641000 260979000 6199000 1291000 294106000 218518000 613946000 480788000 -6186000 -2891000 -6186000 -2891000 1564216000 1434353000 0 0 1564216000 1434353000 0 0 0 0 1098684000 857619000 10735000 14716000 1087949000 842903000 1087949000 842903000 655679000 537786000 432270000 305117000 21565000 15223000 33147000 29670000 47983000 37513000 102695000 82406000 329575000 222711000 645000 2035000 611000 1333000 840000 861000 0 134000 21848000 6678000 23944000 11041000 7000 0 0 411000 13591000 944000 1006000 0 10000 33000 14614000 1388000 338905000 232364000 48311000 25013000 290594000 207351000 290594000 207351000 290594000 207351000 0 0 3.04 2.17 3.03 2.16 290594000 207351000 39076000 37326000 2962000 3005000 0 411000 -611000 -1333000 268000 0 2948000 7981000 44643000 47390000 -36845000 -74445000 -18004000 -46685000 -10752000 5877000 -65601000 -115253000 18335000 27082000 10061000 56011000 29639000 -17020000 -12914000 -5925000 16974000 10408000 -917000 -877000 61178000 69679000 -4423000 -45574000 330814000 209167000 -543080000 -836033000 507202000 760638000 0 -1646000 -36347000 -20702000 -11000 -44000 -1314000 -6368000 -73550000 -104155000 -476702000 0 -476702000 0 -219438000 105012000 372761000 583493000 7000 0 7000 0 16666000 34052000 0 401232000 36828000 23396000 0 -93000 -481000 -2601000 36347000 20702000 955314000 955314000 1142000 260979000 1291000 537784000 800054000 -6199000 -6199000 1750311000 1750311000 4908000 -4908000 0 0 0 290594000 290594000 290594000 290594000 52662000 -52662000 0 0 0 -476702000 -476702000 -476702000 -476702000 13000 13000 13000 13000 0 0 0 0 0 0 0 0 52662000 4908000 -243678000 -186108000 0 0 0 13000 0 0 0 13000 -186095000 0 -186095000 955314000 0 0 0 0 0 955314000 1142000 313641000 6199000 294106000 613946000 0 0 0 -6186000 0 0 0 -6186000 1564216000 0 1564216000 955314000 955314000 1142000 215584000 2080000 457005000 674669000 -1291000 -1291000 1629834000 1629834000 -789000 789000 0 0 0 207351000 207351000 207351000 207351000 45395000 -45395000 0 0 0 -401232000 -401232000 -401232000 -401232000 -1600000 -1600000 -1600000 -1600000 0 0 0 0 0 0 0 0 45395000 -789000 -238487000 -193881000 0 0 0 -1600000 0 0 0 -1600000 -195481000 0 -195481000 955314000 0 0 0 0 0 955314000 1142000 260979000 1291000 218518000 480788000 0 0 0 -2891000 0 0 0 -2891000 1434353000 0 1434353000 勤業眾信聯合會計師事務所 林鴻鵬 黃裕峰 2012-08-24 Y Y Y 1.0000 1.0000 1.0000 0.0000 5189000 5189000 160000 1.0000 4729000 -460000 -460000 4422000 0 150000 1.0000 4430000 8000 8000

XTAI:1733 Apex Biotechnology Corp Quarterly Report Filling

Apex Biotechnology Corp XTAI:1733 Stock - Get Quarterly Report SEC Filing of Apex Biotechnology Corp XTAI:1733 stocks, including company profile, shares outstanding, strategy, business segments, operations, officers, consolidated financial statements, financial notes and ownership information.

Content Partners
XTAI:1733 Apex Biotechnology Corp Quarterly Report Filing - 6/30/2012
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Title |  Date |  Company |  Symbol |  Interest |  Popularity

Previous: XTAI:1733 Apex Biotechnology Corp Quarterly Report Filing - 3/31/2012  |  Next: XTAI:1734 Sinphar Pharmaceutical Co Ltd Quarterly Report Filing - 3/31/2012